The Potential of Ganoderma Lucidum as Antimicrobial Agent for Multidrug- Resistant Mycobacterium Tuberculosis / Meira Erawati, Megah Andriany, Niken Safitri Dyan Kusumaningrum
Background: The problem of bacterial resistance of Mycobacterium tuberculosis should be solved by seeking for alternative substances that potentially inhibit the growth or kill the bacteria. Ganoderma lucidum is one type of fungus which is potential to be an antimicrobial agent. This study aimed to determine the potential of G. lucidum on inhibiting the growth of multidrug-resistant bacteria of M. tuberculosis in vitro. Methods: This study used a solid dilution method to test the extract of G. lucidum as an antibacterial agent. Results and Conclusion: Results showed that all strains of multidrug-resistant tuberculosis (MDR-Tb) gave similar responses to G. lucidum extract at various concentrations. The bacteria did not grow on the medium containing G. lucidum extract at the smallest concentration of 12.5%, as well as concentrations of 25% and 50%. Ganoderma lucidum can be used as one of the alternatives for MDR-Tb drugs in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Anti-infective agents - 16(2018), 1, Seite 11- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Erawati, Meira [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (4 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL008994064 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL008994064 | ||
| 003 | DE-627 | ||
| 005 | 20231129085836.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220323s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL008994064 | ||
| 035 | |a (KFL)prod_DARH_.DD7C2F0E03E7E6A4F593D86BB28B53BDEE012567 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Erawati, Meira |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Potential of Ganoderma Lucidum as Antimicrobial Agent for Multidrug- Resistant Mycobacterium Tuberculosis |c Meira Erawati, Megah Andriany, Niken Safitri Dyan Kusumaningrum |
| 264 | 1 | |c 2018 | |
| 300 | |a 1 Online-Ressource (4 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: The problem of bacterial resistance of Mycobacterium tuberculosis should be solved by seeking for alternative substances that potentially inhibit the growth or kill the bacteria. Ganoderma lucidum is one type of fungus which is potential to be an antimicrobial agent. This study aimed to determine the potential of G. lucidum on inhibiting the growth of multidrug-resistant bacteria of M. tuberculosis in vitro. Methods: This study used a solid dilution method to test the extract of G. lucidum as an antibacterial agent. Results and Conclusion: Results showed that all strains of multidrug-resistant tuberculosis (MDR-Tb) gave similar responses to G. lucidum extract at various concentrations. The bacteria did not grow on the medium containing G. lucidum extract at the smallest concentration of 12.5%, as well as concentrations of 25% and 50%. Ganoderma lucidum can be used as one of the alternatives for MDR-Tb drugs in the future | ||
| 700 | 1 | |a Andriany, Megah |e verfasserin |4 aut | |
| 700 | 1 | |a Kusumaningrum, Niken Safitri Dyan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-infective agents |d Sharjah : Bentham Science, 2012 |g 16(2018), 1, Seite 11- |h Online-Ressource |w (DE-627)KFL000006572 |w (DE-600)2856689-0 |w (DE-576)469947063 |x 2211-3533 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2018 |g number:1 |g pages:11- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=2211-3525&volume=16&issue=1&spage=11 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_DARH_01 | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2018 |e 1 |h 11- | ||